HGXAX
Price
$15.64
Change
+$0.14 (+0.90%)
Updated
Dec 20 closing price
SFCWX
Price
$69.39
Change
-$0.28 (-0.40%)
Updated
Dec 20 closing price
Ad is loading...

HGXAX vs SFCWX

Header iconHGXAX vs SFCWX Comparison
Open Charts HGXAX vs SFCWXBanner chart's image
Hartford Global Impact A
Price$15.64
Change+$0.14 (+0.90%)
VolumeN/A
CapitalizationN/A
American Funds SMALLCAP World F3
Price$69.39
Change-$0.28 (-0.40%)
VolumeN/A
CapitalizationN/A
HGXAX vs SFCWX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HGXAX vs. SFCWX commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGXAX is a StrongBuy and SFCWX is a Buy.

FUNDAMENTALS
Fundamentals
SFCWX has more cash in the bank: 73.6B vs. HGXAX (251M). SFCWX pays higher dividends than HGXAX: SFCWX (0.95) vs HGXAX (0.65). HGXAX was incepted earlier than SFCWX: HGXAX (8 years) vs SFCWX (8 years). HGXAX is a more actively managed with annual turnover of: 34.00 vs. SFCWX (29.00). HGXAX has a lower initial minimum investment than SFCWX: HGXAX (2000) vs SFCWX (1000000). HGXAX annual gain was more profitable for investors over the last year : 10.34 vs. SFCWX (4.67). HGXAX return over 5 years is better than : 34.38 vs. SFCWX (14.96).
HGXAXSFCWXHGXAX / SFCWX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years8 years-
Gain YTD9.2183.494264%
Front LoadN/AN/A-
Min. Initial Investment200010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets251M73.6B0%
Annual Yield % from dividends0.650.9568%
Returns for 1 year10.344.67221%
Returns for 3 years-2.28-11.0121%
Returns for 5 years34.3814.96230%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DMRC36.920.67
+1.85%
Digimarc Corp
DNLI21.45-0.04
-0.19%
Denali Therapeutics
AIM0.19N/A
-0.58%
AIM ImmunoTech
LYEL0.61-0.03
-4.41%
Lyell Immunopharma
XPO135.25-10.26
-7.05%
XPO